Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Viral vectors encoding cancer/testis antigens for use in a method of prevention or treatment of cancer

Viral vectors encoding cancer/testis antigens for use in a method of prevention or treatment of cancer

US Patent 12180501 · Granted Dec 31, 2024

Estimated economic value: $109,426,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adenoviral vector2025
Compositions for inducing an immune response2025
Compositions for inducing an immune response2025
Adenoviral vector2024
Adenoviral vector2022
Treatment and prevention of malaria2017
Recombinant adenylate cyclase toxin of bordetella induces T cell responses again2016
Treatment and prevention of malaria2015
MAGE-C2 antigenic peptides and uses thereof2012
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-32011
MHC class I peptide epitopes from the human 5T4 tumor-associated antigen2011
Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 2009